|
1
|
Lan K, Verma SC, Murakami M, Bajaj B and
Robertson ES: Epstein-Barr virus (EBV): Infection, propagation,
quantitation, and storage. Curr Protoc Microbiol Chapter 14. Unit
14E.2. 2007. View Article : Google Scholar
|
|
2
|
Rasul AE, Nagy N, Sohlberg E, Ádori M,
Claesson HE, Klein G and Klein E: Simultaneous detection of the two
main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1
in single B cells. J Immunol Methods. 385:60–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang Y, Luo C, Cheng A, Lu S, Xu J, Fu T
and Gan R: Expression of latent membrane proteins in Epstein Barr
virus-transformed lymphocytes in vitro. Mol Med Rep. 10:1117–1121.
2014.PubMed/NCBI
|
|
4
|
Gan R, Yin Z, Liu T, Wang L, Tang Y and
Song Y: Cyclosporine A effectively inhibits graft-versus-host
disease during development of Epstein-Barr virus-infected human B
cell lymphoma in SCID mouse. Cancer Sci. 94:796–801. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gan R, Xie X, He J, Liu X, Hong L, Tang Y,
Liu F and Xie H: Gene analysis of Epstein-Barr virus-associated
lymphomas in Hu-Pbl/SCID chimeras. Tumori. 96:465–472.
2010.PubMed/NCBI
|
|
6
|
Klein E, Kis LL and Klein G: Epstein-Barr
virus infection in humans: From harmless to life endangering
virus-lymphocyte interactions. Oncogene. 26:1297–1305. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Canaan A, Haviv I, Urban AE, Schulz VP,
Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, et
al: EBNA1 regulates cellular gene expression by binding cellular
promoters. Proc Natl Acad Sci USA. 106:22421–22426. 2009.
View Article : Google Scholar
|
|
8
|
Klein G, Klein E and Kashuba E:
Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
Biochem Biophys Res Commun. 396:67–73. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang B, Kracker S, Yasuda T, Casola S,
Vanneman M, Hömig-Hölzel C, Wang Z, Derudder E, Li S, Chakraborty
T, et al: Immune surveillance and therapy of lymphomas driven by
Epstein-Barr virus protein LMP1 in a mouse model. Cell.
148:739–751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ramakrishnan R, Donahue H, Garcia D, Tan
J, Shimizu N, Rice AP and Ling PD: Epstein-Barr virus BART9 miRNA
modulates LMP1 levels and affects growth rate of nasal NK T cell
lymphomas. PLoS One. 6:e272712011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tomita M, Dewan MZ, Yamamoto N, Kikuchi A
and Mori N: Epstein-Barr virus-encoded latent membrane protein 1
activates beta-catenin signaling in B lymphocytes. Cancer Sci.
100:807–812. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee CW, Leu SJ, Tzeng RY, Wang SF, Tsai
SC, Sun KH, Chen RH and Huang JC: Latent membrane protein 1 of
Epstein-Barr virus regulates death-associated protein kinase 1 in
lymphoblastoid cell line. Virology. 413:19–25. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rechsteiner MP, Berger C, Zauner L,
Sigrist JA, Weber M, Longnecker R, Bernasconi M and Nadal D: Latent
membrane protein 2B regulates susceptibility to induction of lytic
Epstein-Barr virus infection. J Virol. 82:1739–1747. 2008.
View Article : Google Scholar :
|
|
14
|
Bultema R, Longnecker R and
Swanson-Mungerson M: Epstein-Barr virus LMP2A accelerates
MYC-induced lymphomagenesis. Oncogene. 28:1471–1476. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wasil LR, Tomaszewski MJ, Hoji A and Rowe
DT: The effect of Epstein-Barr virus latent membrane protein 2
expression on the kinetics of early B cell infection. PLoS One.
8:e540102013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guasparri I, Bubman D and Cesarman E: EBV
LMP2A affects LMP1-mediated NF-kappaB signaling and survival of
lymphoma cells by regulating TRAF2 expression. Blood.
111:3813–3820. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Vrazo AC, Chauchard M, Raab-Traub N and
Longnecker R: Epstein-Barr virus LMP2A reduces hyperactivation
induced by LMP1 to restore normal B cell phenotype in transgenic
mice. PLoS Pathog. 8:e10026622012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Do NV, Ingemar E, Phi PT, Jenny A, Chinh
TT, Zeng Y and Hu L: A major EBNA1 variant from Asian EBV isolates
shows enhanced transcriptional activity compared to prototype
B95.8. Virus Res. 132:15–24. 2008. View Article : Google Scholar
|
|
19
|
Chen YL, Liu CD, Cheng CP, Zhao B, Hsu HJ,
Shen CL, Chiu SJ, Kieff E and Peng CW: Nucleolin is important for
Epstein-Barr virus nuclear antigen 1-mediated episome binding,
maintenance, and transcription. Proc Natl Acad Sci USA.
111:243–248. 2014. View Article : Google Scholar
|
|
20
|
Liu X, Tang J, Wang M, Ma Q and Wang Y:
Visual detection and evaluation of latent and lytic gene expression
during Epstein-Barr virus infection using one-step reverse
transcription loop-mediated isothermal amplification. Int J Mol
Sci. 14:23922–23940. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Daskalogianni C, Pyndiah S, Apcher S,
Mazars A, Manoury B, Ammari N, Nylander K, Voisset C, Blondel M and
Fåhraeus R: Epstein-Barr virus-encoded EBNA1 and ZEBRA: Targets for
therapeutic strategies against EBV-carrying cancers. J Pathol.
235:334–341. 2015. View Article : Google Scholar
|
|
22
|
Pagès F, Galon J, Karaschuk G, Dudziak D,
Camus M, Lazar V, Camilleri-Broët S, Lagorce-Pagès C, Lebel-Binay
S, Laux G, et al: Epstein-Barr virus nuclear antigen 2 induces
interleukin-18 receptor expression in B cells. Blood.
105:1632–1639. 2005. View Article : Google Scholar
|
|
23
|
Rowe M, Raithatha S and Shannon-Lowe C:
Counteracting effects of cellular Notch and Epstein-Barr virus
EBNA2: Implications for stromal effects on virus-host interactions.
J Virol. 88:12065–12076. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yue W, Gershburg E and Pagano JS:
Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase
suppresses trans-activation of the LMP1 promoter. J Virol.
79:5880–5885. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Konforte D, Simard N and Paige CJ:
Interleukin-21 regulates expression of key Epstein-Barr virus
oncoproteins, EBNA2 and LMP1, in infected human B cells. Virology.
374:100–113. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Young P, Anderton E, Paschos K, White R
and Allday MJ: Epstein-Barr virus nuclear antigen (EBNA) 3A induces
the expression of and interacts with a subset of chaperones and
co-chaperones. J Gen Virol. 89:866–877. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen A, Zhao B, Kieff E, Aster JC and Wang
F: EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr
virus-immortalized lymphoblastoid cell lines. J Virol.
80:10139–10150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tursiella ML, Bowman ER, Wanzeck KC, Throm
RE, Liao J, Zhu J and Sample CE: Epstein-Barr virus nuclear antigen
3A promotes cellular proliferation by repression of the
cyclin-dependent kinase inhibitor p21WAF1/CIP1. PLoS Pathog.
10:e10044152014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saha A and Robertson ES: Impact of EBV
essential nuclear protein EBNA-3C on B-cell proliferation and
apoptosis. Future Microbiol. 8:323–352. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Portal D, Zhou H, Zhao B, Kharchenko PV,
Lowry E, Wong L, Quackenbush J, Holloway D, Jiang S, Lu Y, et al:
Epstein-Barr virus nuclear antigen leader protein localizes to
promoters and enhancers with cell transcription factors and EBNA2.
Proc Natl Acad Sci USA. 110:18537–18542. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Portal D, Zhao B, Calderwood MA,
Sommermann T, Johannsen E and Kieff E: EBV nuclear antigen EBNALP
dismisses transcription repressors NCoR and RBPJ from enhancers and
EBNA2 increases NCoR-deficient RBPJ DNA binding. Proc Natl Acad Sci
USA. 108:7808–7813. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yokoyama A, Tanaka M, Matsuda G, Kato K,
Kanamori M, Kawasaki H, Hirano H, Kitabayashi I, Ohki M, Hirai K,
et al: Identification of major phosphorylation sites of
Epstein-Barr virus nuclear antigen leader protein (EBNA-LP):
Ability of EBNA-LP to induce latent membrane protein 1
cooperatively with EBNA-2 is regulated by phosphorylation. J Virol.
75:5119–5128. 2001. View Article : Google Scholar : PubMed/NCBI
|
